Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
drug manufacturing
Pharma
AbbVie plots $10B US outlay as pharma tariff threat looms
With the threat of drug tariffs sparking an investment rush in the U.S., AbbVie is laying plans to spend billions in the country over the next decade.
Fraiser Kansteiner
Apr 25, 2025 11:52am
Roche works to mitigate US tariff impact with exemption plea
Apr 24, 2025 10:48am
Lupin recalls nearly 3,000 bottles of OCD drug in US
Apr 24, 2025 9:48am
Compounder in Lilly lawsuit hit with FDA warning letter
Apr 24, 2025 8:20am
US generic drugs could get battered by tariffs, USP chief warns
Apr 23, 2025 4:12pm
Roche to swell US footprint with sweeping $50B investment
Apr 22, 2025 11:10am
